
News|Slideshows|March 27, 2025
Emerging Research and News in Prostate Cancer Imaging — March 2025
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in March 2025.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from monitoring of prostate MRI exams to reduce contrast use to a new meta-analysis on AI and bpMRI for csPCa detection and FDA approval of Gozellix for the preparation of the PSMA PET agent 68Ga gozetotide, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for March 2025.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Breast Imaging in Focus: What New Research Reveals About Contrast-Enhanced Mammography in Prevalence and Incidence Screening Rounds
2
FDA Approves New Tau PET Imaging Agent for Alzheimer’s Disease
3
Diagnostic Imaging’s Weekly Scan: August 9 — August 15
4
Could Photon-Counting CT Supplant Echocardiography for Primary Imaging of Transcatheter Heart Valves?
5











